| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
005 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
60UG/.5ML |
Pre-Filled Syringe |
2013/06/07
|
Sanofi Pasteur Inc. |
Rx |
Licensed |
|
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
006 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
60UG/.5ML |
Single-Dose Vial |
2013/06/07
|
Sanofi Pasteur Inc. |
Disc |
Licensed |
|
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
007 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
60UG/.5ML |
Multi-Dose Vial |
2013/06/07
|
Sanofi Pasteur Inc. |
Rx |
Licensed |
|
N/A |
| Allocord |
125413 |
001 |
351(a) |
HPC, Cord Blood |
Injection |
Intravenous |
TOTAL NUCLEATED CELLS CELL/ML |
Bag |
2013/05/30
|
SSM Cardinal Glennon Children's Medical Center |
Rx |
Licensed |
|
N/A |
| Evarrest |
125392 |
002 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 4x4 IN |
Pouch |
2013/05/16
|
Ethicon, Inc. |
Disc |
Licensed |
|
N/A |
| Simponi |
125289 |
003 |
351(a) |
golimumab |
Injection |
Subcutaneous |
100MG/ML |
Autoinjector |
2013/05/15
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Simponi |
125289 |
004 |
351(a) |
golimumab |
Injection |
Subcutaneous |
100MG/ML |
Pre-Filled Syringe |
2013/05/15
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kcentra |
125421 |
001 |
351(a) |
Prothrombin Complex Concentrate (Human) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2013/04/29
|
CSL Behring GmbH |
Rx |
Licensed |
|
N/A |
| Humira |
125057 |
004 |
351(a) |
adalimumab |
Injection |
Subcutaneous |
40MG/0.8ML |
Single-Dose Vial |
2013/04/24
|
AbbVie Inc. |
Disc |
Licensed |
N/A |
N/A |
| Bat |
125462 |
001 |
351(a) |
Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) |
Solution |
Intravenous |
>4500U |
Single-Dose Vial |
2013/03/22
|
Emergent BioSolutions Canada Inc. |
Rx |
Licensed |
|
N/A |
| Creon |
020725 |
005 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
36,000USP UNITS; 114,000USP UNITS; 180,000USP UNITS |
|
2013/03/14
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kadcyla |
125427 |
001 |
351(a) |
ado-trastuzumab emtansine |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
2013/02/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kadcyla |
125427 |
002 |
351(a) |
ado-trastuzumab emtansine |
For Injection |
Intravenous |
160MG |
Single-Dose Vial |
2013/02/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Privigen |
125201 |
005 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
40G |
Single-Dose Vial |
2013/02/07
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Octaplas |
125416 |
001 |
351(a) |
Pooled Plasma (Human), Solvent/Detergent Treated |
For Injection |
Intravenous |
45-70MG/ML |
Bag |
2013/01/17
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Flublok |
125285 |
001 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
135UG/.5ML |
Single-Dose Vial |
2013/01/16
|
Protein Sciences Corporation |
Rx |
Licensed |
|
N/A |
| Rebif |
103780 |
004 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
8.8MCG/0.2ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rebif |
103780 |
005 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
22MCG/0.5ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rebif |
103780 |
006 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
44MCG/0.5ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Varizig |
125430 |
001 |
351(a) |
Varicella Zoster Immune Globulin (Human) |
For Injection |
Intramuscular |
125IU |
Vial |
2012/12/20
|
Kamada Ltd. |
Disc |
Licensed |
|
N/A |